Sodium Bicarbonate toothpaste efficacy

  • Research type

    Research Study

  • Full title

    300029 - A randomized, controlled, examiner-blind clinical study investigating the effects of a dentifrice containing 67% sodium bicarbonate when used twice daily for 12 weeks on gingivitis treatment and plaque removal

  • IRAS ID

    320327

  • Contact name

    Mizpah Lamptey

  • Contact email

    mizpah.n.lamptey@haleon.com

  • Sponsor organisation

    Haleon formally known as GlaxoSmithKline Consumer Health (GSK CH)

  • Clinicaltrials.gov Identifier

    NCT05654662

  • Duration of Study in the UK

    1 years, 3 months, 0 days

  • Research summary

    GSK markets toothpastes containing 62-67% sodium bicarbonate as specialist gum health toothpastes which facilitate the removal of dental plaque, thereby reducing gum disease. Results from previous studies have demonstrated that toothpastes containing this ingredient reduce plaque and improve gum disease more than standard fluoride toothpastes, but participants in these studies were given a professional clean before the toothpaste was tested this tells us that it works on new plaque. In contrast this study will test if it can help with older plaque. Adults with mild-moderate plaque induced gum disease who consent to take part will be enrolled. After screening, participants gum disease will be assessed (scored) and they will receive a standard fluoride toothpaste to use twice daily for 2 weeks. At baseline, participants gum disease will be re-scored and they will be randomised to one either the sodium bicarbonate test toothpaste or a regular fluoride toothpaste that they will be asked to use twice daily for the 12 weeks instead of their normal toothpaste. Participants will return to the study site again after 3 weeks, 6 weeks and 12 weeks and their gum disease will be assessed. In addition, participants will be asked to complete a diary recording their toothbrushing's from enrolment until the final study appointment. Changes in clinically determined gum inflammation and plaque removal will be assessed at these timepoints.

  • REC name

    Yorkshire & The Humber - Leeds West Research Ethics Committee

  • REC reference

    22/YH/0285

  • Date of REC Opinion

    4 Jan 2023

  • REC opinion

    Further Information Favourable Opinion